Investor profile
Intuitive Ventures
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Intuitive Ventures is the corporate venture arm of Intuitive Surgical, investing $250M+ AUM to shape the future of minimally invasive care. The firm backs bold teams at the intersection of medtech, diagnostics, digital health, and focal therapeutics—companies addressing large unmet patient needs with innovations that transcend conventional thinking. Beyond capital, Intuitive Ventures provides practical guidance drawn from decades of clinical, regulatory, technical, and commercial experience, helping founders navigate healthcare's complexities from early-stage development through global expansion. The firm is 'financially motivated yet strategically bold,' seeking investments that deliver meaningful financial returns while transforming patient outcomes and provider experience.
Notable quotes
“We're architecting a fund that is financially motivated yet strategically bold, focused on the future of minimally invasive care. Our recent investments speak to the most transformative technologies out there that are addressing large unmet needs around the world, both from the patient and the physician's point of view.”
“We are very busy. Venture capital really has no downtime. The best deals have a lot of interest and engagement, and they move quickly. At Intuitive Ventures, we pride ourselves on being able to move at the pace of the market. Investment fundamentals are strong, and we're seeing both later-stage and transformative early-stage opportunities emerge. Good ideas still win.”
“With the acceleration of complex medical device ecosystems in hospitals and homes across the United States, and growing expectations of patients, providers, and device manufacturers to meet higher standards for security protection, proactive and focused cybersecurity solutions are urgently needed. MedCrypt's 'secure by design' product infrastructure will be a critical enabler—and potential standard-setter—for the healthcare industry as stakeholders seek to address the evolving risk profile today.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Cellares | Series D | — | 2026-01-28 |
| Endogenex | Series A | — | 2026-03-25 |
| Apreo Health | Series B | — | 2025-08-06 |
| VahatiCor | Series A | — | 2025-11-07 |
| Capstan Medical | Series C | $110m | 2024-12-11 |
| XII Medical | Series B | $45m | 2024-08-21 |
| Amber Therapeutics | Series A | $100m | 2024-06-10 |
| Neocis | Growth | $20m | 2024-01-10 |
| Medcrypt | Series B | $25m | 2022-11-01 |
| Flywheel | Series D | $54m | 2023-06-26 |
Frequent co-investors
Fit check
Is Intuitive Ventures a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit